4th Quarter - Report
PARRY, ROMANI, DECONCINI & SYMMS for AMGEN USA INC.
Client
Income
$45,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare Part D reimbursement issues dealing with patient payments in the "doughnut hole." No legislation introduced. Monitor PDUFA (Prescription Drug User Fee Act) reauthorization under S. 3187, Food and Drug Administration Safety and Innovation Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD H BAXTER | — |
| JAMES ROCK | — |
| ROMANO ROMANI | — |
| THADDEUS E STROM | — |
| STEVE SYMMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.